AAAAAA
Results:
1-14
|
Results: 14
Authors:
Theodore, D
Fried, MW
Citation: D. Theodore et Mw. Fried, Alternative therapies for chronic hepatitis C, GASTR HEPAT, 8, 2002, pp. 159-186
Authors:
Lasch, HM
Fried, MW
Zacks, SL
Odell, P
Johnson, MW
Gerber, DA
Sandhu, FS
Fair, JH
Shrestha, R
Citation: Hm. Lasch et al., Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome, LIVER TRANS, 7(2), 2001, pp. 147-149
Authors:
Zacks, SL
Fried, MW
Citation: Sl. Zacks et Mw. Fried, Hepatitis B and C and renal failure, INF DIS CL, 15(3), 2001, pp. 877
Authors:
Reddy, KR
Wright, TL
Pockros, PJ
Shiffman, M
Everson, G
Reindollar, R
Fried, MW
Purdum, PP
Jensen, D
Smith, C
Lee, WM
Boyer, TD
Lin, A
Pedder, S
DePamphilis, J
Citation: Kr. Reddy et al., Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared withinterferon alpha-2a in noncirrhotic patients with chronic hepatitis C, HEPATOLOGY, 33(2), 2001, pp. 433-438
Authors:
Fried, MW
Duncan, A
Soroka, S
Connaghan, DG
Farrand, A
Peter, J
Strauss, RM
Boyer, TD
McDonald, GB
Citation: Mw. Fried et al., Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation, BONE MAR TR, 27(6), 2001, pp. 635-639
Authors:
Nolte, FS
Fried, MW
Shiffman, ML
Ferreira-Gonzalez, A
Garrett, CT
Schiff, ER
Polyak, SJ
Gretch, DR
Citation: Fs. Nolte et al., Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICORhepatitis C virus tests, J CLIN MICR, 39(11), 2001, pp. 4005-4012
Authors:
Fried, MW
Citation: Mw. Fried, Clinical research: At the crossroads, GASTROENTY, 121(3), 2001, pp. 515-515
Authors:
Johnson, MW
Thompson, P
Meehan, A
Odell, P
Salm, MJ
Gerber, DA
Zacks, SL
Fried, MW
Shrestha, R
Fair, JH
Citation: Mw. Johnson et al., Internal biliary stenting in orthotopic liver transplantation, LIVER TRANS, 6(3), 2000, pp. 356-361
Authors:
Theodore, D
Fried, MW
Citation: D. Theodore et Mw. Fried, Natural history and disease manifestations of hepatitis C infection, CURR T MICR, 242, 2000, pp. 43-54
Authors:
Khudyakov, YE
Cong, ME
Nichols, B
Reed, D
Dou, XG
Viazov, SO
Chang, J
Fried, MW
Williams, I
Bower, W
Lambert, S
Purdy, M
Roggendorf, M
Fields, HA
Citation: Ye. Khudyakov et al., Sequence heterogeneity of TT virus and closely related viruses, J VIROLOGY, 74(7), 2000, pp. 2990-3000
Authors:
Fried, MW
Shiffman, M
Sterling, RK
Weinstein, J
Crippin, J
Garcia, G
Wright, TL
Conjeevaram, H
Reddy, KR
Peter, J
Cotsonis, GA
Nolte, FS
Citation: Mw. Fried et al., A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: Pretreatment stratification by viral burden and genotype, AM J GASTRO, 95(11), 2000, pp. 3225-3229
Authors:
Cong, ME
Fried, MW
Lambert, S
Lopareva, EN
Zhan, MY
Pujol, FH
Thyagarajan, SP
Byun, KS
Fields, HA
Khudyakov, YE
Citation: Me. Cong et al., Sequence heterogeneity within three different regions of the hepatitis G virus genome, VIROLOGY, 255(2), 1999, pp. 250-259
Authors:
Fong, TL
Fried, MW
Clarke-Platt, J
Citation: Tl. Fong et al., A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy, AM J GASTRO, 94(4), 1999, pp. 990-993
Authors:
Fried, MW
Citation: Mw. Fried, Treatment of hepatocellular carcinoma: Medical options, LIVER TR S, 4(5), 1998, pp. S92-S97
Risultati:
1-14
|